Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Expands By 201.6%

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 281,498 shares, an increase of 201.6% from the May 31st total of 93,339 shares. Based on an average trading volume of 321,156,604 shares, the short-interest ratio is presently 0.0 days. Approximately 34.5% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Wall Street Zen raised Aditxt to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings downgraded shares of Aditxt from a “sell (e+)” rating to a “sell (e)” rating in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Aditxt has a consensus rating of “Sell”.

Insiders Place Their Bets

In other news, major shareholder Financial Lp Hrt sold 3,132,480 shares of Aditxt stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $0.01, for a total value of $31,324.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last three months, insiders sold 3,260,940 shares of company stock worth $45,518. Company insiders own 0.01% of the company’s stock.

Aditxt Stock Up 20.8%

Aditxt stock traded up $0.00 during mid-day trading on Tuesday, reaching $0.00. 21,851,366 shares of the company’s stock were exchanged, compared to its average volume of 125,171,383. The business’s fifty day simple moving average is $2.20 and its 200 day simple moving average is $94.90. The firm has a market capitalization of $2,366.40, a PE ratio of -0.00 and a beta of 0.84. Aditxt has a one year low of $0.00 and a one year high of $32,950.80.

Aditxt (NASDAQ:ADTX) last posted its quarterly earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share for the quarter. Aditxt had a negative net margin of 360,152.50% and a negative return on equity of 374.60%.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.